Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)
- PMID: 17690854
- DOI: 10.1007/s10072-007-0823-z
Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)
Abstract
We have described two cases of Devic's disease patients treated with rituximab with different outcomes. The results indicate that there may be early unresponsiveness in very aggressive cases. Well designed clinical trials are needed to assess treatment effects in such a rare disease.
Comment in
-
Immune agents for the treatment of Devic's neuromyelitis optica.Neurol Sci. 2007 Oct;28(5):238-40. doi: 10.1007/s10072-007-0828-7. Neurol Sci. 2007. PMID: 17972036 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources